These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 11362548)
1. The Inter-Company Collaboration for AIDS Drug Development: boon or bust? Levin J BETA; 1995 Jun; ():65-6. PubMed ID: 11362548 [TBL] [Abstract][Full Text] [Related]
2. Future of ICC debated. Inter-Company Collaboration for AIDS Drug Development. Smart T GMHC Treat Issues; 1995 Jun; 9(6):9. PubMed ID: 11362692 [TBL] [Abstract][Full Text] [Related]
3. Inter-Company Collaboration Combination Trials. Clinical Trial Subcommittee of the Inter-Company Collaboration for AIDS Drug Development. Soo W; Nauss-Karol C; Elkins M; Rooney J; Barry DW J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 2():S92-6. PubMed ID: 7552520 [TBL] [Abstract][Full Text] [Related]
4. Drug companies seek trial participants. AIDS Alert; 1995 Jun; 10(6):82. PubMed ID: 11362432 [TBL] [Abstract][Full Text] [Related]
5. New combo trial/same old style. Gilden D GMHC Treat Issues; 1995 Apr; 9(4):9. PubMed ID: 11362369 [TBL] [Abstract][Full Text] [Related]
7. Drug consortium seeks trial participants. Grodeck B Posit Aware; 1995; ():9. PubMed ID: 11362385 [TBL] [Abstract][Full Text] [Related]
8. ICC Trials -- first study enrolling. James JS AIDS Treat News; 1995 Mar; (no 219):8. PubMed ID: 11362334 [TBL] [Abstract][Full Text] [Related]
9. Major protease inhibitor triple combination trial begins soon: CD4 under 200, AZT experienced, 3TC naive. James JS AIDS Treat News; 1995 Dec; (no 237):3. PubMed ID: 11363075 [TBL] [Abstract][Full Text] [Related]
10. Expanded access to the protease inhibitor drugs. Baker R BETA; 1995 Jun; ():67. PubMed ID: 11362549 [TBL] [Abstract][Full Text] [Related]
11. New trial proposed for when drugs fail. James JS AIDS Treat News; 1995 May; (no 223):1-4. PubMed ID: 11362467 [TBL] [Abstract][Full Text] [Related]
12. AZT, ddI, and ddC combinations at FDA advisory hearing. Food and Drug Administration. James JS AIDS Treat News; 1996 Apr; (no 244):6. PubMed ID: 11363307 [TBL] [Abstract][Full Text] [Related]
17. Roche investigators say Invirase does not cause cross-resistance to other protease inhibitors. Baker R BETA; 1995 Sep; ():5. PubMed ID: 11362895 [TBL] [Abstract][Full Text] [Related]
18. Protease inhibitor update: treatment combination strategies. Mascolini M AIDS Treat News; 1996 Jan; (no 239):3. PubMed ID: 11363085 [TBL] [Abstract][Full Text] [Related]